Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00211562 · ClinicalTrials.gov registry record · Phase 3
Adjunctive Supplementation of Antioxidants (Vitamins E + C) Plus Omega-3 Fatty Acids
A Phase 3 study, sponsored by Augusta University.
- Terminated
- Registry status
- Phase 3
- Development phase
- 20
- Enrollment target
NCT00211562 is a Phase 3 study that was terminated before completion, run by Augusta University. The registered enrollment target is 20 participants.
The verdict
NCT00211562, a Phase 3 study, was terminated before completion, sponsored by Augusta University.
- TERMINATED
- Registry status
- Phase 3
- Development phase
- 20 participants
- Enrollment target
Study Summary
This research study helps to demonstrate that adding vitamins and fats (nutritional supplements) to a diet will help reduce body weight and improve the lipid profile. This will be done by examining the body weight and chemicals in the blood. The chemicals are the result of the brain using the fat that subjects eat in their diet. Some medications may also change the amount of these chemicals in a person's blood.
Interventions
- DRUG Olanzapine, Omega 3, Vitamin E+C
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2005-10 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00211562
The ClinicalTrials.gov registry entry for NCT00211562 describes a study currently listed as terminated, categorized as Phase 3. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Augusta University, which has 106 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Olanzapine, Omega 3, Vitamin E+C is the first listed.
NCT00211562 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00211562 about?
NCT00211562 is a clinical study titled "Adjunctive Supplementation of Antioxidants (Vitamins E + C) Plus Omega-3 Fatty Acids". This research study helps to demonstrate that adding vitamins and fats (nutritional supplements) to a diet will help reduce body weight and improve the lipid profile. This will be done by examining the body weight and chemicals in the blood. The chemicals are the result of the brain using the fat th...
What is the current status of trial NCT00211562?
This trial is currently terminated. It is a Phase 3 study. The enrollment target is 20 participants. The study started on 2005-10.
What interventions are being tested in trial NCT00211562?
The interventions under investigation include: Olanzapine, Omega 3, Vitamin E+C (DRUG).
Who is sponsoring clinical trial NCT00211562?
This trial is sponsored by Augusta University, which has 106 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.